Nis register study comparing Seroquel and Seroquel Prolong

Study identifier:NIS-NFI-SER-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A local non interventional retrospective register study of the current clinical treatment practices and the number of hospitalization days with Seroquel or Seroquel Prolong.

Medical condition

Comparing hospitalisation time with Seroquel and Seroquel Prolong

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

200

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Aug 2009

Primary Completion Date: 01 Dec 2010

Study Completion Date: 01 Dec 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Lappeenranta, Finland

Arms	Assigned Interventions
1 Seroquel	-
2 Seroquel Prolong	-

"There is no result for the study"

Documents available

CSR-NIS-NFI-SER-2009-1
Download
CSR-NIS-NFI-SER-2009-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Finland Clinical Study Information

+358 10 23 010

Investigators

Principal Investigator

Yrjö Ovaskainen

Medical Affairs Manager, MD, psychiatrist